Clinicopathological Features and Prognostic Role of HER2 Low in Early Breast Cancer: A real world study

被引：0
作者：
Kong, Ziqing
Zhao, Weihong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-02-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-02-07
引用
收藏
页数：3
相关论文
共 50 条
[41]   HER2 low and ER low breast cancer [J].
Schnitt, Stuart .
JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1) :S7-S7
[42]   A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer [J].
Sheffield, Kristin M. ;
Peachey, Jessica R. ;
Method, Michael ;
Grimes, Brenda R. ;
Brown, Jacqueline ;
Saverno, Kim ;
Sugihara, Tomoko ;
Cui, Zhanglin Lin ;
Lee, Kimberley T. .
FUTURE ONCOLOGY, 2022, 18 (21) :2667-2682
[43]   In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer [J].
Spears, Melanie ;
Taylor, Karen J. ;
Munro, Alison F. ;
Cunningham, Carrie A. ;
Mallon, Elizabeth A. ;
Twelves, Chris J. ;
Cameron, David A. ;
Thomas, Jeremy ;
Bartlett, John M. S. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) :463-470
[44]   HER2 expression and its clinicopathological features in resectable gastric cancer [J].
Yoshiki Kataoka ;
Hiroshi Okabe ;
Akihiko Yoshizawa ;
Sachiko Minamiguchi ;
Kenichi Yoshimura ;
Hironori Haga ;
Yoshiharu Sakai .
Gastric Cancer, 2013, 16 :84-93
[45]   HER2 expression and its clinicopathological features in resectable gastric cancer [J].
Kataoka, Yoshiki ;
Okabe, Hiroshi ;
Yoshizawa, Akihiko ;
Minamiguchi, Sachiko ;
Yoshimura, Kenichi ;
Haga, Hironori ;
Sakai, Yoshiharu .
GASTRIC CANCER, 2013, 16 (01) :84-93
[46]   Clinicopathological Features and Endoscopic Findings of HER2 Positive Gastric Cancer [J].
Oono, Yasuhiro ;
Osera, Shozo ;
Yoda, Yusuke ;
Kato, Tomoji ;
Morimoto, Hiroyuki ;
Shinmura, Kensuke ;
Imajoh, Maomi ;
Kadota, Tomohiro ;
Takashima, Kenji ;
Nakamura, Hiroshi ;
Hombu, Takuya ;
Ikematsu, Hiroaki ;
Yano, Tomonori ;
Kaneko, Kazuhiro .
GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) :AB567-AB567
[47]   Decoding HER2 dynamics: Exploring HER2 expression across a real-world breast cancer cohort. [J].
Mattighatta Bhojanna, Shreegowri ;
Strickland, Kyle C. ;
Dillard, Alicia ;
Jaggessarsingh, Dana ;
Klein, Jonathan ;
Wallen, Zachary D. ;
Biorn, Michael D. ;
Newburn, Erin ;
Severson, Eric ;
Jensen, Taylor J. ;
Ramkissoon, Shakti ;
Previs, Rebecca A. ;
Ko, Heidi C. ;
Toumeh, Anis .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL)
[48]   Prognostic factors in non-metastatic HER2 'low' and HER2 'negative' breast cancer: single institute experience [J].
Turkel, Alper ;
Dogan, Mutlu ;
Sertesen, Elif ;
Karacin, Cengiz ;
Irkkan, Sultan cigdem ;
Ates, Ozturk .
WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (11-12) :340-346
[49]   Real world outcomes in elderly patients with HER2 positive advanced breast cancer [J].
Evans, Nicole ;
Anton, Angelyn ;
Wong, Rachel ;
Lok, Sheau Wen ;
De Boer, Richard ;
Malik, Laeeq ;
Greenberg, Sally ;
Yeo, Belinda ;
Nott, Louise ;
Richardson, Gary ;
Collins, Ian M. ;
Torres, Javier ;
Barnett, Frances ;
Gibbs, Peter ;
Devitt, Bianca .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 :135-135
[50]   Prognostic role of plasma HER2 gene copy number in patients with HER2 positive metastatic breast cancer. [J].
Ran, Ran ;
Huang, Wenfa ;
Lin, Shao ;
Niu, Yunyun ;
Rugo, Hope S. ;
Kong, Weiyao ;
Bo, Shiping ;
Lu, Sijia ;
Li, Huiping .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345